Evaluation of P53 Mutation in Uterine Serous Carcinoma

被引：0
|
作者：
Bandyopadhyay, Sudeshna [1 ]
Elshaikh, Mohamed [2 ]
Abada, Evi [1 ]
Fucinari, Juliana [3 ]
Fehmi, Omar [4 ]
Ruterbusch, Julie [5 ]
Dyson, Greg [6 ]
Schultz, Daniel [7 ]
Cote, Michele [1 ]
Ali-Fehmi, Rouba [1 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Karmanos Canc Inst, Detroit, MI USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Wayne State Univ, Sch Med, Detroit, MI USA
[6] Wayne State Univ, Detroit Med Ctr, Detroit, MI USA
[7] Henry Ford Hlth Syst, Detroit, MI USA
来源：
MODERN PATHOLOGY | 2021年 / 34卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
539
引用
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [21] p53 gene mutation in thyroid carcinoma
    Ho, YS
    Tseng, SC
    Chin, TY
    Hsieh, LL
    Lin, JD
    CANCER LETTERS, 1996, 103 (01) : 57 - 63
  • [22] Correlation of p53 Immunohistochemical Expression with TP53 Mutation in Extrauterine High-Grade Serous Carcinoma
    Karim, Lina Abdul
    Yang, Richard
    Ramalingam, Preetha
    Lawson, Barrett
    Malpica, Anais
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 639 - 640
  • [23] Correlation of p53 Immunohistochemical Expression with TP53 Mutation in Extrauterine High-Grade Serous Carcinoma
    Karim, Lina Abdul
    Yang, Richard
    Ramalingam, Preetha
    Lawson, Barrett
    Malpica, Anais
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 639 - 640
  • [24] P53 IMMUNOREACTIVITY AND MUTATION OF THE P53 GENE IN SMOOTH-MUSCLE TUMORS OF THE UTERINE CORPUS
    JEFFERS, MD
    FARQUHARSON, MA
    RICHMOND, JA
    MCNICOL, AM
    JOURNAL OF PATHOLOGY, 1995, 177 (01): : 65 - 70
  • [25] High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma
    Katharina Bischof
    Stian Knappskog
    Ingunn Stefansson
    Emmet Martin McCormack
    Jone Trovik
    Henrica Maria Johanna Werner
    Kathrine Woie
    Bjorn Tore Gjertsen
    Line Bjorge
    BMC Cancer, 18
  • [26] High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma
    Bischof, Katharina
    Knappskog, Stian
    Stefansson, Ingunn
    McCormack, Emmet Martin
    Trovik, Jone
    Werner, Henrica Maria Johanna
    Woie, Kathrine
    Gjertsen, Bjorn Tore
    Bjorge, Line
    BMC CANCER, 2018, 18
  • [27] The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix
    Lee, Sul
    Lee, Hyun Joo
    Choi, Kyung Un
    Kwon, Byung Su
    Suh, Dong Soo
    Jeong, Dae Hoon
    Kim, Geun Joo
    Lee, Tae Hwa
    Roh, Hyun-Jin
    Kim, Ki Hyung
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2020, 25
  • [28] Distinct subtypes of serous ovarian carcinoma identified by p53 determination
    Lassus, H
    Leminen, A
    Lundin, J
    Lehtovirta, P
    Butzow, R
    GYNECOLOGIC ONCOLOGY, 2003, 91 (03) : 504 - 512
  • [29] Significant Overexpression of HMGAs in Serous Ovarian Carcinoma in Association with p53
    Mahajan, A.
    Gellert, L.
    Yang, X. J.
    Wei, J.
    MODERN PATHOLOGY, 2009, 22 : 226A - 226A
  • [30] P53 and bcl-2 assessment in serous ovarian carcinoma
    Palmer, J. E.
    Cassia, L. J. Sant
    Irwin, C. J.
    Morris, A. G.
    Rollason, T. P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) : 241 - 248
12345